Steele Foundation for Hope is a self-funded 501(c)(3) private foundation that provides patient, philanthropic investment capital to for-profit companies and social enterprises developing products and services addressing global humanitarian challenges in healthcare, water, food, and education.
33% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Their most common stage is series-b (44% of deals). Average disclosed round size is $18.7M (across 8 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Sibel Health | Series C | $39M | Oct 2025 |
 Epicore Biosystems | Series B | $32M | May 2025 |
| Epicore Biosystems | Series B | $26M | Feb 2025 |
| Sibel Health | Series C | — | Jan 2025 |
| Sibel Health | Series B | $20M | Aug 2022 |
 Zenysis Technologies, Inc. | Series B | $13.3M | Jun 2022 |
| Zenysis Technologies, Inc. | Unknown | $13.3M | Jan 2022 |
| WWater Access Rwanda | Seed | $1M | — |
| AAI Diagnostics | Unknown | $5.2M | — |
Top Co-Investors
Last updated: 20 October 2026